Cargando…
Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer
Epithelial ovarian cancer (EOC) is the most lethal of all gynecological malignancies in the UK. Recent evidence has shown that there is potential for immunotherapies to be successful in treating this cancer. We have previously shown the effective application of combinations of traditional chemothera...
Autores principales: | Wahba, John, Natoli, Marina, Whilding, Lynsey M., Parente-Pereira, Ana C., Jung, Youngrock, Zona, Stefania, Lam, Eric W.-F., Smith, J. Richard, Maher, John, Ghaem-Maghami, Sadaf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208825/ https://www.ncbi.nlm.nih.gov/pubmed/30167862 http://dx.doi.org/10.1007/s00262-018-2199-8 |
Ejemplares similares
-
Synergy between liposomal zoledronic acid and γδ T-cells in the treatment of epithelial ovarian cancer
por: Pereira, Ana Catarina Parente, et al.
Publicado: (2013) -
Correction to: Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade
por: Natoli, Marina, et al.
Publicado: (2020) -
Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade
por: Natoli, Marina, et al.
Publicado: (2020) -
CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies
por: Whilding, Lynsey M., et al.
Publicado: (2019) -
Is ovarian cancer surgery stuck in the dark ages?: a commentary piece reviewing surgical technologies
por: Phelps, David L., et al.
Publicado: (2020)